• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Minerals
    Tech
    Life Science
    Life Science Market
    Life Science News
    Life Science Stocks
    • Life Science Market
    • Life Science News
    • Life Science Stocks

    TEXT ME Study Reveals How Apps Can Help Manage Cardiovascular Disease

    Morag Mcgreevey
    Sep. 23, 2015 07:57AM PST
    Life Science Investing

    TEXT ME, a study using text messages to improve management of cardiovascular disease, offered examples of how mobile applications can be used to manage health conditions.

    TEXT ME, a study using text messages to improve management of cardiovascular disease, offered examples of how mobile applications can be used to manage health conditions.
    According to Med City News:

    An editorial citing the study noted that the process for clinical validation could use some improvement and offered some recommendations.
    For those unfamiliar with it, the TEXT ME randomized clinical trial (short for Tobacco, Exercise and Diet Messages) sent text messages with advice, motivation and information on diet, physical activity and smoking cessation to roughly half of the 710 participants with cardiovascular disease over a six-month period. The rest did not receive them. It then compared LDL levels, blood pressure and other relevant data. Those who received the text messages showed statistically significant, albeit modest, improvement compared with those who did not.
    Drs. Zubin Eapen and Eric Peterson of Duke Clinical Research Institute, who wrote the editorial, liked the way the investigators worked with patients (as well as academics and clinicians) both in structuring the messages sent to participants. They were part of the collaboration process for developing the messages used in the study. The study also tracked patients’ use of text messages and satisfaction with them. Their insights could easily apply to the broader clinical validation programs underway at companies and institutions.

    Click here to read the full article on Med City News.


     
    The Conversation (0)

    Go Deeper

    AI Powered
    Cardiex Limited (ASX:CDX)

    Cardiex Limited

    2025 Life Science Outlook: Australia Edition

    2025 Life Science Outlook: Australia Edition

    Latest News

    InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline

    Numinus Wellness Advises of a Change of Auditor

    More News

    Outlook Reports world

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Life Science Investing Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES